39 research outputs found
The Mbd1-Atf7ip-Setdb1 pathway contributes to the maintenance of X chromosome inactivation.
BackgroundX chromosome inactivation (XCI) is a developmental program of heterochromatin formation that initiates during early female mammalian embryonic development and is maintained through a lifetime of cell divisions in somatic cells. Despite identification of the crucial long non-coding RNA Xist and involvement of specific chromatin modifiers in the establishment and maintenance of the heterochromatin of the inactive X chromosome (Xi), interference with known pathways only partially reactivates the Xi once silencing has been established. Here, we studied ATF7IP (MCAF1), a protein previously characterized to coordinate DNA methylation and histone H3K9 methylation through interactions with the methyl-DNA binding protein MBD1 and the histone H3K9 methyltransferase SETDB1, as a candidate maintenance factor of the Xi.ResultsWe found that siRNA-mediated knockdown of Atf7ip in mouse embryonic fibroblasts (MEFs) induces the activation of silenced reporter genes on the Xi in a low number of cells. Additional inhibition of two pathways known to contribute to Xi maintenance, DNA methylation and Xist RNA coating of the X chromosome, strongly increased the number of cells expressing Xi-linked genes upon Atf7ip knockdown. Despite its functional importance in Xi maintenance, ATF7IP does not accumulate on the Xi in MEFs or differentiating mouse embryonic stem cells. However, we found that depletion of two known repressive biochemical interactors of ATF7IP, MBD1 and SETDB1, but not of other unrelated H3K9 methyltransferases, also induces the activation of an Xi-linked reporter in MEFs.ConclusionsTogether, these data indicate that Atf7ip acts in a synergistic fashion with DNA methylation and Xist RNA to maintain the silent state of the Xi in somatic cells, and that Mbd1 and Setdb1, similar to Atf7ip, play a functional role in Xi silencing. We therefore propose that ATF7IP links DNA methylation on the Xi to SETDB1-mediated H3K9 trimethylation via its interaction with MBD1, and that this function is a crucial feature of the stable silencing of the Xi in female mammalian cells
Genetic architecture of heart mitochondrial proteome influencing cardiac hypertrophy.
Mitochondria play an important role in both normal heart function and disease etiology. We report analysis of common genetic variations contributing to mitochondrial and heart functions using an integrative proteomics approach in a panel of inbred mouse strains called the Hybrid Mouse Diversity Panel (HMDP). We performed a whole heart proteome study in the HMDP (72 strains, n=2-3 mice) and retrieved 848 mitochondrial proteins (quantified in â„50 strains). High- resolution association mapping on their relative abundance levels revealed three trans-acting genetic loci on chromosomes (chr) 7, 13 and 17 that regulate distinct classes of mitochondrial proteins as well as cardiac hypertrophy. DAVID enrichment analyses of genes regulated by each of the loci revealed that the chr13 locus was highly enriched for complex-I proteins (24 proteins, P=2.2E-61), the chr17 locus for mitochondrial ribonucleoprotein complex (17 proteins, P=3.1E-25) and the chr7 locus for ubiquinone biosynthesis (3 proteins, P=6.9E-05). Follow-up high resolution regional mapping identified NDUFS4, LRPPRC and COQ7 as the candidate genes for chr13, chr17 and chr7 loci, respectively, and both experimental and statistical analyses supported their causal roles. Furthermore, a large cohort of Diversity Outbred mice was used to corroborate Lrpprc gene as a driver of mitochondrial DNA (mtDNA)-encoded gene regulation, and to show that the chr17 locus is specific to heart. Variations in all three loci were associated with heart mass in at least one of two independent heart stress models, namely, isoproterenol-induced heart failure and diet-induced obesity. These findings suggest that common variations in certain mitochondrial proteins can act in trans to influence tissue-specific mitochondrial functions and contribute to heart hypertrophy, eluci- dating mechanisms that may underlie genetic susceptibility to heart failure in human populations
A genome-wide association study identifies risk alleles in plasminogen and P4HA2 associated with giant cell arteritis
Giant cell arteritis (GCA) is the most common form of vasculitis in individuals older than 50 years in Western countries. To shed light onto the genetic background influencing susceptibility for GCA, we performed a genome-wide association screening in a well-powered study cohort. After imputation, 1,844,133 genetic variants were analysed in 2,134 cases and 9,125 unaffected controls from ten independent populations of European ancestry. Our data confirmed HLA class II as the strongest associated region (independent signals: rs9268905, P = 1.94E-54, per-allele OR = 1.79; and rs9275592, P = 1.14E-40, OR = 2.08). Additionally, PLG and P4HA2 were identified as GCA risk genes at the genome-wide level of significance (rs4252134, P = 1.23E-10, OR = 1.28; and rs128738, P = 4.60E-09, OR = 1.32, respectively). Interestingly, we observed that the association peaks overlapped with different regulatory elements related to cell types and tissues involved in the pathophysiology of GCA. PLG and P4HA2 are involved in vascular remodelling and angiogenesis, suggesting a high relevance of these processes for the pathogenic mechanisms underlying this type of vasculitis
BHPR research: qualitative1.âComplex reasoning determines patients' perception of outcome following foot surgery in rheumatoid arhtritis
Background: Foot surgery is common in patients with RA but research into surgical outcomes is limited and conceptually flawed as current outcome measures lack face validity: to date no one has asked patients what is important to them. This study aimed to determine which factors are important to patients when evaluating the success of foot surgery in RA Methods: Semi structured interviews of RA patients who had undergone foot surgery were conducted and transcribed verbatim. Thematic analysis of interviews was conducted to explore issues that were important to patients. Results: 11 RA patients (9 â, mean age 59, dis dur = 22yrs, mean of 3 yrs post op) with mixed experiences of foot surgery were interviewed. Patients interpreted outcome in respect to a multitude of factors, frequently positive change in one aspect contrasted with negative opinions about another. Overall, four major themes emerged. Function: Functional ability & participation in valued activities were very important to patients. Walking ability was a key concern but patients interpreted levels of activity in light of other aspects of their disease, reflecting on change in functional ability more than overall level. Positive feelings of improved mobility were often moderated by negative self perception ("I mean, I still walk like a waddling duckâ). Appearance: Appearance was important to almost all patients but perhaps the most complex theme of all. Physical appearance, foot shape, and footwear were closely interlinked, yet patients saw these as distinct separate concepts. Patients need to legitimize these feelings was clear and they frequently entered into a defensive repertoire ("it's not cosmetic surgery; it's something that's more important than that, you know?â). Clinician opinion: Surgeons' post operative evaluation of the procedure was very influential. The impact of this appraisal continued to affect patients' lasting impression irrespective of how the outcome compared to their initial goals ("when he'd done it ... he said that hasn't worked as good as he'd wanted to ... but the pain has goneâ). Pain: Whilst pain was important to almost all patients, it appeared to be less important than the other themes. Pain was predominately raised when it influenced other themes, such as function; many still felt the need to legitimize their foot pain in order for health professionals to take it seriously ("in the end I went to my GP because it had happened a few times and I went to an orthopaedic surgeon who was quite dismissive of it, it was like what are you complaining aboutâ). Conclusions: Patients interpret the outcome of foot surgery using a multitude of interrelated factors, particularly functional ability, appearance and surgeons' appraisal of the procedure. While pain was often noted, this appeared less important than other factors in the overall outcome of the surgery. Future research into foot surgery should incorporate the complexity of how patients determine their outcome Disclosure statement: All authors have declared no conflicts of interes
A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility
We conducted a large-scale genetic analysis on giant cell arteritis (GCA), a polygenic immune-mediated vasculitis. A case-control cohort, comprising 1,651 case subjects with GCA and 15,306 unrelated control subjects from six different countries of European ancestry, was genotyped by the Immunochip array. We also imputed HLA data with a previously validated imputation method to perform a more comprehensive analysis of this genomic region. The strongest association signals were observed in the HLA region, with rs477515 representing the highest peak (p = 4.05 Ă 10â40, OR = 1.73). A multivariate model including class II amino acids of HLA-DRÎČ1 and HLA-DQα1 and one class I amino acid of HLA-B explained most of the HLA association with GCA, consistent with previously reported associations of classical HLA alleles like HLA-DRB1â04. An omnibus test on polymorphic amino acid positions highlighted DRÎČ1 13 (p = 4.08 Ă 10â43) and HLA-DQα1 47 (p = 4.02 Ă 10â46), 56, and 76 (both p = 1.84 Ă 10â45) as relevant positions for disease susceptibility. Outside the HLA region, the most significant loci included PTPN22 (rs2476601, p = 1.73 Ă 10â6, OR = 1.38), LRRC32 (rs10160518, p = 4.39 Ă 10â6, OR = 1.20), and REL (rs115674477, p = 1.10 Ă 10â5, OR = 1.63). Our study provides evidence of a strong contribution of HLA class I and II molecules to susceptibility to GCA. In the non-HLA region, we confirmed a key role for the functional PTPN22 rs2476601 variant and proposed other putative risk loci for GCA involved in Th1, Th17, and Treg cell function
Human Embryonic Stem Cells Do Not Change Their X Inactivation Status during Differentiation
Recommended from our members
The Regulation of X Chromosome Inactivation in Human Development and Pluripotent Stem Cells
The following thesis addresses how the epigenetic state of the female X chromosome reflects the developmental stage captured by human embryonic stem cells (hESCs). This topic has been controversial, as many epigenetic states of the X chromosome have been proposed to exist in female human pluripotent stem cells; however, none of the described states captures the state of the X chromosome in the human embryo. To investigate the basis for this disconnect between human pluripotent stem cells and human development, we used single cell resolution techniques in conjunction with mapping of DNA methylation and global transcription to examine the epigenome and transcriptome of pre-implantation embryos, cells during derivation, and in established hESCs. We demonstrate that X chromosome inactivation (XCI) initiates early during derivation of female hESCs, and unlike mouse development, progresses from a naĂŻÂżÂœve state where XIST is expressed on two active chromosomes to a state where XIST is expressed on one inactive X chromosome. Therefore, the majority of established female hESCs display a pattern resembling the mouse post-implantation embryo, with one X chromosome silenced, which is associated with the spreading and coating of the non-coding RNA (ncRNA) XIST. However, this pattern erodes during progressive culture of female hESCs, with Xist RNA loss and subsequent partial activation of genes on the Xi, to an extent that is unpredictable. We also find that de novo XCI can be stochastically disrupted during hESC derivation, leading to a state where XIST is permanently silenced thus that XCI cannot occur in vitro. Accordingly some established female hESC lines carry two active X chromosomes in the self- renewing state, but, unlike the prevailing model suggests, do not undergo X chromosome inactivation (XCI) nor undergo dosage compensation upon induction of differentiation. Finally, we find that no existing method is capable of reproducing the epigenetic environment of the pre-implantation embryo in established human pluripotent stem cell lines, and conclude that a female human pluripotent stem cell that is competent to undergo XCI has not been attained. My work places the seemingly confusing findings regarding human pluripotency and the X chromosome into context and also highlights the need for a revision of culture conditions to stabilize the naĂŻÂżÂœve, pre-implantation state of pluripotency in human cells
Mole-Fraction Engineering in Germanium Source Pocket Based Tunnel Field Effect Transistor
Improving the content of high value compounds in Nordic Desmodesmus microalgal strains
Nordic Desmodesmus microalgal strains (2â6) and (RUC-2) were exposed to abiotic stress (light and salt) to enhance lipids and carotenoids. The biomass output of both strains increased by more than 50% during light stress of 800 ÎŒmol mâ2 sâ1 compared to control light. The biomass of Desmodesmus sp. (2â6) contained most lipids (15% of dry weight) and total carotenoids (16.6 mg gâ1) when grown at moderate light stress (400 ÎŒmol mâ2 sâ1), which further could be enhanced up to 2.5-fold by salinity stress. Desmodesmus sp. (RUC-2) exhibited maximal lipid (26.5%) and carotenoid (43.8 mg Lâ1) content at light intensities of 400 and 100 ÎŒmol mâ2 sâ1, respectively. Salinity stress stimulated lipid accumulation by 39%. Nordic Desmodesmus strains therefore are not only able to tolerate stress conditions, but their biomass considerably improves under stress. These strains have high potential to be used in algal bio-factories on low-cost medium like Baltic seawater
KYC As A Service (KASE) - A Blockchain Approach
International audienceKYC or Know-Your-Customer is an integral part of the onboarding process of a customer for a company. This process requires independent and tedious verification of a customer's identity documents by the businesses leading to wastage of resources. In this paper, we propose a solution where the submission and verification of a customer is done only once, and the results are shared with the businesses which require the information. The proposed system uses blockchain to record and manage the KYC requests and ensure transparency. The KYC data is verified using machine learning processes to ensure further efficiency in the process by reducing a significant amount of time spent on verifying the customers